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ABSTRACT
Background: IgA deficiency (IgAD) is the most common immunodeficiency, however the pathogenesis in
most cases of IgAD is unknown. There are 2 subclasses of IgA, IgA1 and IgA2, and its heavy chains are en-
coded by 2 different genes, the α1 and α2 genes. To investigate the molecular pathogenesis of IgA deficiency,
it is important to evaluate each of the expressions of IgA1 and IgA2 separately.
Methods: In this study, we report on the reverse transcriptase (RT)-PCR method in which α1 and α2 mRNAs
can be separately evaluated. This method is based on electrophoretic separation using the difference of 39
bases between α1 and α2 mRNAs. Three selective, 5 partial and 2 secondary IgAD patients were examined.
Results: In the 3 selective IgAD patients, no α1 or α2 mRNA expression was detected. In the 5 partial IgAD
patients, various α1 and α2 mRNA expression patterns were found. One of the partial IgAD patients showed
only α2 gene expression, but not α1 gene expression, and was found to show an α1 gene deletion together
with γ2 and ε gene deletions. His plasma IgA2 level was within the normal range.
Conclusions: Patients with an α1 gene deletion can be considered as having partial IgAD. Using this method,
we identified the second case of α1 gene deletion in Japan, and classified IgAD patients on the basis of α1 and
α2 expression.
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ABBREVIATIONS
IgA, immunoglobulin A; IgAD, immunoglobulin A deficiency; RT, reverse transcriptase; CVID, common variable
immunodeficiency; TACI, transmembrane activator and calcium-modulator and cyclophilin ligand interactor;
SD, standard deviation; PBMCs, peripheral blood mononuclear cells; GAPDH, glyceraldehyde-3-phosphate
dehydrogenase; ELISA, enzyme-linked immunosorbent assay; HRP, horseradish peroxidase; BSA, bovine se-
rum albumin; PBS, phosphate-buffered saline
INTRODUCTION
Human immunoglobulin A (IgA) is the most abun-
dant immunoglobulin in secretions. IgA has 2 sub-
classes, IgA1 and IgA2. The ratios of IgA1 : IgA2 are
approximately 9 : 1 in serum and 6 : 4 in saliva.1 In
mucosal tissue, IgA synthesis greatly exceeds that of
other immunoglobulin classes. These 2 subclasses
play important roles in the first line of defense, and
the amount ratio of these molecules in secretions var-
ies.
Selective IgA deficiency (IgAD) is the most com-
mon immunodeficiency, and has been found with a
frequency ranging from 0.03 to 0.3%. The prevalence
differs according to ethnic groups, with a lower fre-
quency in the Japanese population, namely, 118,000
people.2,3 Most IgAD patients remain healthy, but
some suffer from a variety of infections, allergies,
autoimmune disorders, gastrointestinal diseases, ma-
lignancies, endocrinopathies, neurological diseases,
and genetic disorders.2,4 The pathogenesis of IgAD
has not yet been completely clarified. IgAD has been
found to be associated with IgG2, IgG4, and IgE defi-
ciencies.5-8 The class switch disorder in IgA-
producing B lymphocytes is one of the most impor-
tant factors in IgAD patients.9 Asano et al. suggested
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Table 1 Immunological data of patients
IgG subclass（mg/dl）Serum level（mg/dl）
AgeSexPatient No.
IgG4IgG3IgG2IgG1IgMIgAIgG
Selective IgA deficiency
33.957.3255619146＜5136310 yearsM 1
90.247.7400949117＜5164011 yearsF 2
18.435.1625630137＜5126117 yearsF 3
Partial IgA deficiency
＜3.022.8＜8.09331201712234 yearsM 4
32.117.347.98781501516443 yearsF 5
3.827.669.3306106278693 yearsF 6
4.440.097.0295101458874 yearsM 7
＜3.074.71201090100816244 yearsM 8
Secondary IgA deficiency
16.552.8148602105129137 yearsF 9
6.449.834585239970513 yearsM10
that decreased expression levels of Iα germline tran-
scripts before a class switch may be the cause of se-
lective IgAD, and B-cell differentiation might be dis-
turbed after a class switch in partial IgAD patients.10
Husain et al. reported that the increased destruction
of a subset of B cells is the cause for the inability to
produce IgA in IgAD patients.11
The association between IgAD and common vari-
able immunodeficiency (CVID) has been discussed,3
and it was reported recently that some CVID and
IgAD patients have mutations in TNFRSF13B (encod-
ing TACI; transmembrane activator and calcium-
modulator and cyclophilin ligand interactor).12,13
The molecular weights of the IgA1 and IgA2 heavy
chains are both approximately 53 kD. The α1 and α2
genes show about 97% of its identity.14 This high ho-
mology between them makes it difficult to analyze
the α1 and α2 genes separately. The α-chain constant
region of both α1 and α2 genes is encoded by 3 ex-
ons. The hinge region of the human α chain is en-
coded at the beginning of the second exon. The
hinge region of the α2 gene shows a deletion of 39
nucleotides (corresponding to 13 amino acids) when
compared with that of the α1 gene.1,15 To clarify the
pathogenesis and immunological reactions of IgAD
clear, we analyzed α1 and α2 gene expression in
IgAD patients. In this study, we devised a new
method to determine the expression levels of the α1
and α2 genes, and analyzed selective, partial and sec-
ondary IgAD patients.
METHODS
SUBJECTS
As shown in Table 1, we analyzed 3 selective IgAD
patients (patients number 1, 2 and 3) with serum IgA
levels below the detection limit (<5 mgdl), 5 partial
IgAD patients (patients number 4, 5, 6, 7, and 8) with
serum IgA levels above 5 mgdl but having more
than 2 standard deviations (SDs) below the normal
level, and 2 secondary IgAD patients (patients num-
ber 9 and 10) whose conditions were caused by epi-
leptic medication. Ten controls were also included in
this study. Two of the 10 controls were child volun-
teers under 16 years of age, and the other 8 were
adult volunteers 16 years or older. We obtained in-
formed consent from the patients, controls, and par-
ents of minors.
CELL PREPARATION
Peripheral blood mononuclear cells (PBMCs) were
collected in heparin and separated by gradient cen-
trifugation in Ficoll-Paque (GE Healthcare Bio-
Sciences AB, Uppsala, Sweden).16 The cells were sus-
pended at a density of 106ml and incubated for 24
hours in RPMI 1640 medium supplemented with 10%
heat-inactivated fetal calf serum, 2 mmoll l-
glutamine, 100 Uml penicillin and 100 μgml strep-
tomycin.10 In comparison with non-cultured cells,
cells cultured for 24 hours showed higher levels of α1
and α2 gene expression (unpublished data).
cDNA SYNTHESIS AND PCR AMPLIFICATION
We extracted total RNA from PBMCs using an Iso-
gen kit (Nippon Gene, Tokyo, Japan), and cDNA syn-
thesis was carried out using 1 or 2 μg of total RNA
with oligo-dT and M-MLV reverse transcriptase (Invi-
trogen, Carlsbad, CA, USA). We used the following
PCR primer pair, which was targeted to the common
sequence area of the α1 and α2 genes: sense 5’-
CCTGGTCACCGTCTCCTCA-3’ (placed at the J
exon; Gene Bank accession number-L20778) and an-
tisense 5’-TCACGCTCAGGTGGTCCTTG-3’ (placed
at the Cα CH2 exon)17 (Fig. 1A). The PCR fragments
included the CH1, hinge and CH2 regions, and the
size was 532 bp for the α1 gene and 493 bp for the α2
gene. The PCR program was 35 or 40 cycles of 94℃
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Fig. 1 Structure and expression of the α1 and α2 genes. (A) The primer pair was targeted to the com-
mon sequence area of the α1 and α2 genes. These figures show mature Cα gene transcripts. The arows 
indicate the positions of the primers. The black box indicates the deletion of 39 bases. VDJ: variable diver-
sity joining region, CH: constant heavy chain. (B) RT-PCR analysis of RNA extracted from the PBMCs of 
a control subject, starting from 1 μl or 2 μl of cDNA and using 35 or 40 cycles. The two lanes at the left 
show PCR products amplified from the template DNA, which are T-vectors containing the IgA1 (lane 1) or 
IgA2 (lane 2) genes. (C) RT-PCR analysis of RNA extracted from the PBMCs of control subjects and 
IgAD patients. The α1 fragment, α2 fragment, and hetero-duplex formation are indicated by arows. 
GAPDH was used as a control.
(A)
VDJ
VDJ
Hinge 
region
CH1
CH1
Hinge 
region
Cα1
Cα2
sense anti-sense
sense anti-sense
5’ 3’
5’ 3’
CH3CH2
CH3CH2
1 2 21
Controls Selective
IgAD patients
Partial
IgAD patients
Secondary
IgAD patients
GAPDH 
α2
hetero-duplex 
formation
α1
(C)
(B)
α2
hetero-duplex 
formation
α1
40354035Cycles
cDNA 1 μl 2 μl 
1 μl cDNA 
35 cycles
2 μl cDNA 
40 cycles
α2
hetero-duplex 
formation
α1
3 4 5 6 7 8 9 10
for 1 minute, 60℃ for 1 minute, and 72℃ for 1 minute
using 1 or 2 μl of cDNA. The PCR products were run
on 4% agarose gels for 120 minutes. Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) was used as a
control.
DNA EXTRACTION AND PCR AMPLIFICATION
Genomic DNA was purified from polymorphonuclear
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cells using Sepa Gene (Sanko Junyaku, Tokyo, Ja-
pan). We used the following PCR primer pair, which
was targeted at the common sequence area of the α1
and α2 genes: sense 5’-TGACCAGCTCAGGCCATCT
CT-3’ and antisense 5’-CTTTGCAAACCAGAGCACT
GA-3’. The PCR program was 40 cycles of 94℃ for 1
minute, 58℃ for 1 minute, and 72℃ for 1 minute.
Four percent agarose gel electrophoresis was per-
formed for 120 minutes. The other primer pairs were
as follows: for amplification of the Cε gene, sense 5’-A
CCTTCAGCGGTAAGAGAGGG-3’ and antisense 5’-T
GGGAACGTACCTGCACACTT-3’, (the PCR program
was 35 cycles of 94℃ for 1 minute, 60℃ for 1 minute,
and 72℃ for 1 minute); for amplification of the Cγ2
gene, sense 5’-ATCTCTTCCTCAGCACCACCT-3’ and
antisense 5’-CGTGGCACTCATTTACCCGGA-3’, (the
PCR program was 35 cycles of 94℃ for 1 minute, 58
℃ for 1 minute, and 72℃ for 1 minute); for the Cμ
gene, sense 5’-ATGTGTGTCCCCGGTGAGTGA-3’
and antisense 5’-AGGGCCACCCCTGTGAACAGA-3’,
(the PCR program was 35 cycles of 94℃ for 1 minute,
58℃ for 1 minute, and 72℃ for 1 minute).
QUANTIFICATION OF IgA SUBCLASSES IN
PLASMA
The levels of the IgA subclasses in plasma were
measured by enzyme-linked immunosorbent assay
(ELISA). For IgA1, coating was performed with a
mouse monoclonal anti-IgA1 (NI69-11), and detection
of IgA1 was performed with horseradish peroxidase
(HRP)-labeled goat anti-human IgA (Cappel, Organon
Teknika, Turnhout, Belgium).18 For IgA2, coating
was performed using goat anti-human IgA (BETHYL,
Montgomery, TX, USA), and detection of IgA2 was
performed using mouse anti-human IgA2-HRP
(B3506B4).19 ELISA plates were coated overnight at 4
℃ with mouse monoclonal anti-IgA1 (diluted to 1 :
200 with 0.05 M sodium carbonate, pH 9.6) or goat
anti-human IgA (diluted to 1 : 100 with 0.05 M so-
dium carbonate, pH 9.6). The plates were washed
then incubated with standard serum and plasma dilu-
tions. IgA1 was detected using goat anti-human IgA-
HRP (diluted to 1 : 10000 with 1% bovine serum albu-
min [BSA] in phosphate-buffered saline [PBS]-0.02%
Tween 20), and IgA2 was detected using mouse anti-
human IgA2-HRP (diluted to 1 : 1000 with 1% BSA in
PBS-0.02% Tween 20). The samples were tested re-
peatedly. The lower limits of IgA1 and IgA2 detection
were 5 ngml and 1 μgml, respectively.
RESULTS
PCR AMPLIFICATION OF α1 AND α2 GENE
EXPRESSION
RT-PCR analysis was performed using primer pairs
that amplified both α1 and α2 mRNAs and could dis-
tinguish α2 mRNA from α1 mRNA taking advantage
of the deletion of 39 bases in the hinge region of the
α2 gene. Various PCR conditions were tested, and
the optimal conditions were deemed to be 2 μl of
cDNA and 40 cycles of amplification (Fig. 1B). Con-
trol samples gave an intense α1 band and a less-
intense, shorter α2 band in all 4 PCR conditions. An-
other band with less electrophoretic mobility than the
α1 band was determined to be a hetero-duplex forma-
tion of the α1 and α2 fragments, because the subclon-
ing of this band yielded clones of the α1 and α2 frag-
ments. Figure 1C shows α1 and α2 gene expression
in 10 IgAD patients. In 3 selective IgAD patients (pa-
tients number 1, 2 and 3), no expression of the α1
and α2 genes was detected. Three partial IgAD pa-
tients (patients number 5, 6 and 7) and 2 secondary
IgAD patients (patients number 9 and 10) showed α2
and α1 gene expressions; however, patient No. 4
showed only α2 gene expression, but no α1 gene ex-
pression. One partial IgAD patient (No. 8) showed no
bands in this RT-PCR analysis.
PLASMA IgA LEVELS IN CONTROLS AND IgAD
PATIENTS
Plasma IgA1 and IgA2 levels were assayed separately
(Table 2). The IgA1 levels were much higher than
the IgA2 levels in the 10 controls. In the 3 selective
IgAD patients, plasma IgA1 and IgA2 levels were very
low. One partial IgAD patient (patient No. 4) had a
normal IgA2 level, but no detectable IgA1. This find-
ing is in accordance with the result of this patient
showing no α1 gene expression in PBMCs. Although
the IgA2 level of patient No. 5 was below the thresh-
old, other patients with partial IgAD (patients number
6, 7, 8) showed various IgA1 and IgA2 levels although
these levels were much lower than that of the control
group.
PCR AMPLIFICATION OF THE IMMUNOGLOBU-
LIN GENES OF IgAD PATIENTS
In patient No. 4, α1 gene expression was not detected
and no IgA1 protein was detected in his plasma. As
shown in Table 1, the plasma levels of the IgG sub-
classes showed that IgG2 and IgG4 levels were below
the detection limits. Hence, we carried out PCR am-
plification of the genomic α2 and α1 genes, together
with the μ, γ2 and ε genes. As shown in Figure 2, no
PCR products were detected for the α1, γ2 and ε
genes in patient No. 4, whereas they were clearly be
detected in 2 control and other IgAD patients. A large
genomic deletion of the A1-GP-G2-G4-E genes can be
proposed as the molecular basis of IgAD in patient
No. 4.
LONGITUDINAL CHANGE IN THE SERUM IgA
LEVEL OF PATIENT NO. 4
The immunological data of 2 families of patients with
IgG2-IgG4-IgA1-IgE deficiency, including patient No.
4, are shown in Table 3. The serum IgA levels of pa-
tient No. 4 over time are shown in Table 4. The pa-
tient’s IgA levels remained at a level more than 2 SDs
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Table 2 The levels of IgA subclasses and IgA1/IgA2 ratios in plasma as measured by ELISA
GenesmRNA expression
IgA1/IgA2 ratio
Plasma IgA1 and IgA2 levels（mg/dl）Serum IgA
levels（mg/dl）Patient No. α2α1α2α1IgA2IgA1
Selective IgA deficiency
＋＋§－－¶NC‡ND†2.48±0.26＜5 1
＋＋－－NCNDND＜5 2
＋＋－－NCND2.16±0.74＜5 3
Partial IgA deficiency
＋－＋－NC13.67±1.39 ND17 4
＋＋＋＋NCND2.71±0.3615 5
＋＋＋＋8.400.91±0.258.28±0.5227 6
＋＋＋＋6.974.88±0.5429.29±6.83 45 7
＋＋－－8.870.86±0.456.28±0.678 8
Secondary IgA deficiency
＋＋＋＋6.561.17±0.368.59±1.7712 9
＋＋＋＋3.030.18±0.030.56±0.09910
7.96±4.1419.39±8.93 128.02±36.98 Controls（n＝10）
†ND：undetected, ‡NC：not calculated.
§＋：detected, ¶－：undetected.
Fig. 2 PCR analysis of immunoglobulin genes in IgAD patients. PCR analysis of α1, α2, ε, γ2 and μ 
genes was performed in control subjects and IgAD patients. Two diferent sized bands for the α gene ap
peared, coresponding to the α1 and α2 genes, as indicated by arows.
Controls Selective
IgAD patients
Partial
IgAD patients 
α1
α2
ε
γ2
μ
Secondary
IgAD patients
1 2 21 3 4 5 6 7 8 9 10
below the normal value, but above 5 mgdl. The im-
munological data of his family members are shown in
Family 1 (Table 3). The patient’s older brother was
also found to have the same gene deletion. His serum
IgA level was 21 mgdl, and he also showed a pattern
of partial IgAD. The serum IgA levels of another pa-
tient with IgG2-IgG4-IgA1-IgE deficiency and her
family members are shown as Family 2 (Table 3).8
Both the patient and her older sister had the same
deletions of the A1-GP-G2-G4-E genes. The serum
IgA level of the patient’s sister was 18 mgdl and she
also showed a pattern of partial IgAD.
DISCUSSION
The serum IgA subclass levels of IgAD patients, par-
ticularly selective IgAD patients, are very difficult to
measure by ELISA; thus, there have been few reports
on the levels of serum IgA subclasses in IgAD pa-
tients. The α1 and α2 gene expression levels are low
in most IgAD patients, and there have been no previ-
ous reports on the gene expression levels of the IgA
subclasses in these patients.20-23 Hummelshoj et al.
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Table 3 Immunological data of patient no. 4 and 2 families of patients with IgG2-IgG4-IgA1-IgE deficiency
Family 1
Serum level
Age IU/mlmg/dl
IgEIgG4IgG3IgG2IgG1IgA
＜2.0＜3.022.8＜8.093317 4Patient No. 4
70.019.058.045165911945Father
190.014.225.422473020141Mother
＜2.0＜3.023.3＜8.09522111Brother
Family 2
Serum level
Age IU/mlmg/dl
IgEIgG4IgG3IgG2IgG1IgA
＜5.0＜3.010.4＜8.0996＜5 1Patient
214.814.113.728172016127Father
4.28.216.724879418026Mother
＜5.0＜3.015.1＜8.064518 3Sister
Table 4 Longitudinal change in the serum IgA levels of patient no. 4
57m56m38m30m25m20m
172011111211Serum IgA level (mg/dl)
4y3y2y1yearNormal value†
89 (31―202)74 (25―174)60 (20―149)49 (16―128)Mean (±2SD)
†data on normal values according to reference 28.
reported on the expression of germline transcripts of
the α1 and α2 genes in IgAD patients.24 The germ-
line transcripts were induced during stimulation with
TGF-β, however their levels were lower than those of
control subjects. Our report shows the expression of
mature transcripts of the α1 and α2 genes in partial
IgAD patients. In the 3 selective IgAD patients, no ex-
pression of α1 and α2 genes was detected, presum-
ably because the expression level was too low. In 2 of
them, only plasma IgA1 levels could be measured,
and in 1 of them, neither IgA1 nor IgA2 levels were
unable to be measured. Patient No. 8 showed no
mRNA expression of IgA subclasses, but exhibited
detectable levels of plasma IgA1 and IgA2 levels. It
might be assumed that the pathogenesis of partial
IgAD in patient No. 8 is similar to that in selective
IgAD patients. As shown in Table 2, patients number
1, 2, 3 and 8 showed no α1 or α2 gene expression,
while patients number 5, 6, 7, 9 and 10 showed both
α1 and α2 gene expression. There is a possibility that
the mechanism underlying IgA deficiency may be dif-
ferent between these 2 groups. The plasma IgA2 lev-
els were unable to be measured in 1 partial IgAD pa-
tient; however, α2 gene expression was seen in this
patient using our method. This method is effective for
determining whether partial IgAD patients lack ex-
pression of the α1 and α2 genes when their plasma
IgA, IgA1 and IgA2 levels are under the detection
limit.
Asano et al. reported detectable levels of the Cα
mature transcripts by RT-PCR using the same sense
primer we employed and an antisense primer located
in the Cα CH1 region.10 Using our method, no α1 or
α2 gene expression was detected in 3 selective IgAD
patients. There was a difference in the annealing tem-
peratures used (59℃ in the study of Asano et al.),
and different PCR conditions may result due to
changes in the sensitivity of the assay.
IgAD patients are often associated with IgG sub-
class deficiency. In our study, 2 IgAD patients (pa-
tients number 4 and 8) had IgG subclass deficiency in
the serum. Patient No. 4 showed deletions of the γ2
and ε genes, and was considered to have a large
genomic deletion of the Cα1, ΨCγ, Cγ2, Cγ4 and Cε
genes, showing the same observations reported pre-
viously in a patient.8 In Japan, only 1 case has ever
been reported. Beard et al.25 reported that IgA-IgG2-
IgG4 deficiency occurs in 4% of 73 IgAD patients. De-
letions of the A1-GP-G2-G4-E genes are the most
common deletions of the Ig heavy chain locus.26
There could be more patients with an α1 gene dele-
tion who might have partial IgAD. Partial IgAD is
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often transient,27 however, patients who have a dele-
tion of the α gene will not show transient IgAD and
will exhibit continuous partial IgAD.
We also classified the IgAD patients on the basis of
the expression of α1 and α2 genes. Selective IgAD
patients showed no α1 or α2 mRNA expression and
extremely low protein levels, while secondary IgAD
patients showed both mRNA and protein expressions
of IgA subclasses. Partial IgAD can be classified into
3 patterns as follows: cases showing reduced levels of
α1 and α2 gene expression; cases showing no α1
gene expression but normal α2 gene expression; and
cases showing no α1 or α2 gene expression.
It is sometimes difficult to determine the patho-
genic mechanisms operative in IgAD patients on the
basis of serum IgA levels. Variations in the patho-
genesis of IgAD patients might become better under-
stood by examining the protein and mRNA expres-
sion levels of IgA subclasses.
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